CIK 0001498382 · Non-accelerated filer<br>Smaller reporting company
TuHURA Biosciences, Inc./NV
Sign in to watch- Ticker
- HURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 990360497
- Phone
- 813-875-6600
- Business address
- 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
- Former names
- Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
- 4 Open-market buy Director bought 2,083 shares at $3.60 ($7,499)
- 4 Open-market buy Director bought 4,167 shares at $3.60 ($15,001)
- 4 Open-market buy CEO bought 6,700 shares at $3.60 ($24,120)
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 10,000 shares at $2.12 ($21,200)
- 4 Open-market buy Chief Financial Officer bought 9,500 shares at $2.10 ($19,950)
- 4 Open-market buy CEO bought 5,000 shares at $2.12 ($10,600)
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 2,500 shares at $2.20 ($5,500)
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- 424B5 Offering Prospectus
- 4 Other acquisition Director acquired 74 shares (other)
- 4 Other acquisition Chief Executive Officer acquired 176 shares (other)
- 4 Other acquisition Chief Financial Officer acquired 211 shares (other)
- 4 Other acquisition Director acquired 528 shares (other)
- 4 Other acquisition Director acquired 71 shares (other)
- 4 Other acquisition Chief Scientific Officer acquired 169 shares (other)
Page 33 of 47 · 929 filings